UroGen Pharma (URGN) Debt Ratio (2022 - 2026)

UroGen Pharma's (URGN) quarterly Debt Ratio came in at 0.75 in Q1 2026, up 51.5% YoY from 0.49 in Q1 2025, and up 22.54% on a QoQ basis from 0.61 in Q4 2025.

UroGen Pharma (URGN) Debt Ratio (2022 - 2026) Analysis & Trends

UroGen Pharma (URGN) has 5 years of Debt Ratio data on file, last reported at 0.75 in Q1 2026.

  • Quarterly Debt Ratio rose 51.5% year-over-year to 0.75 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.75 (up 51.5% YoY) and the FY2025 annual result came in at 0.61, up 43.09% from the prior year.
  • Debt Ratio rose to 0.75 in Q1 2026, from 0.61 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.03 in Q2 2023 to a low of 0.35 in Q2 2024.
  • A 5-year average of 0.58 and a median of 0.55 in 2023 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2023 — Debt Ratio soared 111.58% — and 2024, when it tumbled 66.33%.
  • Tracing URGN's Debt Ratio over 5 years: stood at 0.72 in 2022, then declined by 23.15% to 0.55 in 2023, then fell by 22.91% to 0.43 in 2024, then jumped by 43.09% to 0.61 in 2025, then climbed by 22.54% to 0.75 in 2026.
  • The last three Debt Ratio figures came in at 0.75 (Q1 2026), 0.61 (Q4 2025), and 0.66 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 UroGen Pharma 2.36 Bn 2.25 Bn 65.88 Mn 0.75

Historic Data

Download Data
DateValue
Jun 30, 2026 0.75
Mar 31, 2026 0.75
Dec 31, 2025 0.61
Sep 30, 2025 0.66
Jun 30, 2025 0.59
Mar 31, 2025 0.49
Dec 31, 2024 0.43
Sep 30, 2024 0.40
Jun 30, 2024 0.35
Mar 31, 2024 0.49
Dec 31, 2023 0.55
Sep 30, 2023 0.51
Jun 30, 2023 1.03
Mar 31, 2023 0.87
Dec 31, 2022 0.72
Sep 30, 2022 0.56
Jun 30, 2022 0.49
Mar 31, 2022 0.43